Miller Eden, Raj Dominic, Cavender Matthew A, Mehanna Sherif, Namvar Tarlan, Ochsner Reese
Diabetes and Obesity Care LLC, Bend, OR, USA.
Division of Kidney Diseases and Hypertension, The George Washington University, Washington, DC, USA.
Postgrad Med. 2023 Sep;135(7):708-716. doi: 10.1080/00325481.2023.2256209. Epub 2023 Sep 11.
Chronic kidney disease (CKD) and atherosclerotic cardiovascular disease (ASCVD) are closely linked conditions, and the presence of each condition promotes incidence and progression of the other. In this study, we sought to better understand the medical journey of patients with CKD and ASCVD and to uncover patients' and healthcare providers' (HCPs) perceptions and attitudes toward CKD and ASCVD diagnosis, treatment, and care coordination.
Cross-sectional, US-population-based online surveys were conducted between May 18, 2021, and June 17, 2021, among 239 HCPs (70 of whom were primary care physicians, or PCPs) and 195 patients with CKD and ASCVD.
PCPs reported personally diagnosing CKD in 78% and ASVD in 64% of their patients, respectively. PCPs reported they are more likely to serve as the overall coordinator of their patient's care (89%), while slightly more than half of PCPs self-identified as a patient's coordinator of care specifically for CKD (54%) or ASCVD (59%). In contrast, patients viewed their PCP as their coordinator of care for CKD (25%) or ASCVD (9%). PCPs who personally treated patients with CKD and ASCVD most often recalled primarily prescribing or recommending pharmacologic treatments for CKD and ASCVD; however, patients reported that lifestyle modification was the most common treatment modality they had ever used to manage CKD and ASCVD.
CKD and ASCVD are interrelated cardiometabolic conditions with underlying risk factors that can be managed in a primary care setting. However, few patients in our study considered their PCP to be the coordinator of their care for CKD or ASCVD. PCPs can and should take a more active role in educating patients and coordinating care for those with CKD and ASCVD.
慢性肾脏病(CKD)与动脉粥样硬化性心血管疾病(ASCVD)密切相关,且每种疾病的存在都会促使另一种疾病的发生和进展。在本研究中,我们试图更好地了解CKD和ASCVD患者的就医历程,并揭示患者及医疗服务提供者(HCPs)对CKD和ASCVD诊断、治疗及护理协调的看法和态度。
2021年5月18日至2021年6月17日期间,在美国人群中开展了横断面在线调查,调查对象为239名医疗服务提供者(其中70名是初级保健医生,即PCPs)以及195名患有CKD和ASCVD的患者。
初级保健医生报告称,他们分别亲自诊断出78%的患者患有CKD,64%的患者患有ASVD。初级保健医生报告称,他们更有可能担任患者护理的总体协调人(89%),而略超过一半的初级保健医生自我认定为专门针对CKD(54%)或ASCVD(59%)的患者护理协调人。相比之下,患者将其初级保健医生视为其CKD(25%)或ASCVD(9%)护理的协调人。亲自治疗CKD和ASCVD患者的初级保健医生最常回忆起主要为CKD和ASCVD开处方或推荐药物治疗;然而,患者报告称,生活方式改变是他们过去用于管理CKD和ASCVD最常见的治疗方式。
CKD和ASCVD是相互关联的心脏代谢疾病,其潜在风险因素可在初级保健环境中得到管理。然而,在我们的研究中,很少有患者认为他们的初级保健医生是其CKD或ASCVD护理的协调人。初级保健医生可以而且应该在教育患者以及协调CKD和ASCVD患者的护理方面发挥更积极的作用。